シェバ医療センター
| イスラエル | トルコ | オーストリア | |
| 膀胱摘出術 | から $28,500 | から $8,000 | から $22,000 |
| 膀胱全摘除術及び再建術 | から $31,500 | から $15,000 | から $32,000 |
| 腹腔内温熱化学療法 | から $61,200 | から $22,500 | から $40,000 |
| 乳癌化学療法 | から $22,500 | から $1,200 | から $15,000 |
| キイトルーダ療法 | から $9,800 | から $3,300 | から $15,000 |
この医師は化学療法と放射線療法の専門家であり、乳がん、子宮がん、前立腺がん、消化管がん、肺がん、腎臓がん、膀胱がんを含む様々な腫瘍性疾患の治療に焦点を当てています。医師は化学療法、放射線療法、生物学的がん治療などの先進的な治療法を用い、がん治療後のリハビリテーションも提供しています。
1988年からの経験を持ち、2009年からSourasky (Ichilov) Medical Centerで上級腫瘍専門医として勤務しており、Rambam Medical CenterおよびSourasky Medical Centerで重要な役職を歴任しています。医師は30以上の科学論文に貢献しており、がん治療の臨床試験にも関与しています。
メリムスキー教授は、骨・軟部腫瘍科をスーラスキー医療センターにて率いており、整形外科腫瘍学において41年の経験の経験を有しています。
Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.
She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.
Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Israel treats bladder cancer using advanced surgical and oncological protocols tailored to tumor invasiveness. Primary methods include robotic-assisted cystectomy, transurethral resection (TURBT), and innovative therapies like hyperthermic intravesical chemotherapy and checkpoint inhibitors. Specialized centers like Sourasky Medical Center report a 90% average success rate for oncology treatments.
Bookimed Expert Insight: Israeli oncology centers often provide specialized access to combined protocols not widely available elsewhere. For example, Sheba Medical Center is a global leader in CAR-T and TIL immunotherapies. Patients requesting complex care can find comprehensive packages, such as those at Sourasky Medical Center for $52,300, which include preoperative tests, anesthesia, and internal transfers.
Patient Consensus: Patients note that using blue light cystoscopy during surgery helps catch more tumors than standard procedures. Many emphasize the importance of getting a remote second opinion from Israeli specialists to refine treatment plans for invasive cancer.
Israel leads in bladder cancer care through JCI-accredited centers like Sheba, Sourasky, and Hadassah. These facilities utilize da Vinci robotic systems for radical cystectomy and advanced immunotherapy protocols. Top uro-oncologists include Dr. Vladimir Yutkin and Prof. Jack Baniel, specializing in nerve-sparing reconstructions and bladder preservation.
Bookimed Expert Insight: While most patients focus on hospital rankings, the real differentiator in Israel is the surgeon-selection model at private centers. At Assuta, patients can choose their specific attending physician. This is vital for bladder reconstruction, where outcomes depend heavily on a surgeon like Prof. Jack Baniel, who has published over 100 scientific articles on the procedure.
Patient Consensus: Patients note that traveling to the Tel Aviv centers is essential for accessing clinical trials and aggressive treatment options. Many emphasize that meeting with doctors at Hadassah provided peace of mind when choosing complex robotic procedures.
Israeli oncology centers provide comprehensive bladder-sparing protocols and minimally invasive surgeries for bladder cancer. These options utilize robotic-assisted systems and advanced immunotherapy like Pembrolizumab. Accredited facilities like Sourasky and Hadassah maintain a 90% success rate for oncology treatments through multidisciplinary approaches.
Bookimed Expert Insight: While many patients undergo open surgery elsewhere, our data shows a shift toward robotics in Israel. Dr. Vladimir Yutkin has performed over 300 robotic procedures for kidney and bladder. This volume at centers like Hadassah often leads to faster recovery and better preservation of nerve function.
Patient Consensus: Patients note it is important to request a detailed discussion of all options like TMT or robotic surgery. Many emphasize getting a second opinion before agreeing to a full bladder removal.
International patients typically stay in Israel for 10 to 14 days for bladder cancer surgery. This duration covers preoperative diagnostics, the surgical procedure, and post-operative monitoring. Major surgeries like radical cystectomy require longer stays. Smaller procedures typically allow for a shorter 6-day visit.
Bookimed Expert Insight: Data shows that premier Israeli centers like Sheba and Sourasky prioritize high-volume surgical expertise to streamline stays. Dr. Vladimir Yutkin at Hadassah has performed over 300 robotic surgeries, which often leads to faster discharge. Choosing a center with specialized robotic platforms can reduce your required recovery days in the hospital.
Patient Consensus: Patients note it is important to book flexible return flights to account for recovery speed. Many survivors recommend staying near the hospital for several days after discharge to handle potential post-op needs like catheter management or stent removal.